Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan · Delayed Price · Currency is JPY 7,003.00
+2.00 (0.03%)
Nov 10, 2026, 3:30 PM JST
Kobayashi Pharmaceutical Market Cap
Kobayashi Pharmaceutical has a market cap or net worth of 520.59 billion as of November 10, 2026. It is the 4,816th most valuable company in the world and the 347th biggest in Japan. Its market cap has increased by 31.54% in one year.
Market Cap
520.59B
Enterprise Value
464.00B
Revenue
167.47B
Global Rank
Country Rank
#347 Japan
PE Ratio
320.36
ChartMarket Cap Chart
Since August 17, 1999, Kobayashi Pharmaceutical's market cap has increased from 245.70B to 520.59B, an increase of 111.88%. That is a compound annual growth rate of 2.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 520.59B | 29.02% |
| Dec 30, 2025 | 403.51B | -12.87% |
| Dec 30, 2024 | 463.13B | -8.08% |
| Dec 29, 2023 | 503.84B | -22.52% |
| Dec 30, 2022 | 650.29B | -7.68% |
| Dec 30, 2021 | 704.43B | -28.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unicharm | 1.86T |
| Shiseido Company | 1.56T |
| Rohto Pharmaceutical | 628.29B |
| Lion Corporation | 582.45B |
| KOSE Holdings | 347.09B |
| Pola Orbis Holdings | 317.32B |
| MTG Co., Ltd. | 315.37B |
| Pigeon | 270.68B |